Bridgebio Oncology Therapeutics, Inc. (BBOT)

2.41 +0.21 (+9.55%) USD  |  NASDAQ  |  Nov 11, 13:48
More

Bridgebio Oncology Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Korsana Biosciences, Inc. Upgrade
IRulya Therapeutics, Inc. --
PepGen Inc. --
Q32 Bio, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade